# Medicare Program; Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022
> **Centers for Medicare and Medicaid Services** · Final rule. · Published 2023-11-08 · Effective 2024-01-08 · 88 FR 77150
## Document
- **Document number:** 2023-24407
- **Category:** medicare
- **Sub-agency:** Centers for Medicare and Medicaid Services
- **Federal Register citation:** 88 FR 77150
- **CFR reference:** 42 CFR 419
- **Publication date:** 2023-11-08
- **Effective date:** 2024-01-08
- **HHS docket:** CMS-1793-F
## Abstract

This final rule describes the agency's actions on remand from the United States (U.S.) District Court for the District of Columbia to craft a remedy in light of the U.S. Supreme Court's decision in American Hospital Association v. Becerra, 142 S. Ct. 1896 (2022), relating to the adjustment of Medicare payment rates for drugs acquired under the 340B Program from calendar year (CY) 2018 through September 27th of CY 2022.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2023/11/08/2023-24407/medicare-program-hospital-outpatient-prospective-payment-system-remedy-for-the-340b-acquired-drug)
---
*AI Analytics · CC0 1.0*